Formulation And Evaluation Of Self Emulsifying Drug Delivery System For Poorly Water Soluble Drug
Keywords:
Monophasic, Dissolution, Solubility, Morbidity, ImmunocompromisedAbstract
By enhancing NVP's solubility, dissolution rate, and diffusion profile, the current work aimed to develop and optimize Posaconazole (PN) self-emulsifying drug delivery systems (SEDDS) to improve oral absorption. When added to the aqueous phase with little agitation, SEDDS—isotropic mixes of oil, surfactant, co-surfactant, and medication—form an oil-in-water microemulsion
Downloads
References
McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. Trends in mortality due to invasive mycotic diseases in the United States, 1980–1997. Clin Infect Dis. 2001;33(5):641–647. doi: 10.1086/322606.
Kauffman CA. Fungal infections. Proc Am Thorac Soc. 2006;3(1):35–40. doi: 10.1513/pats.200510-110JH.
Noxafil (posaconazole) oral suspension [package insert] Kenilworth, NJ: Schering Corp; 2006.
Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005;5(12):775–785. doi: 10.1016/S1473-3099(05)70297-8.
Pallavi M, Swapnil L. Self-emulsifying drug delivery system (SEDDS) Indian J Pharm Biol Sci. 2012;2:42–52.
Bajaj H. Self-emulsifying delivery system: An approach to enhance bioavailability. Int J Pharm Res Dev. 2008;3:59–75.
Khoo SM, Humberstone AJ, Porter CJ, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm. 1998;167:155–64.
Iwanaga K, Kushibiki T, Miyazaki M, Kakemi M. Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs. Biol Pharm Bull. 2006;29:508–12. doi: 10.1248/bpb.29.508.
Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63:288–94. doi: 10.1016/j.ejpb.2005.12.005
Lachman L., Liberman H. A. and Kanig J. L. The Theory and Practice of Industrial Pharmacy, Varghese publishing House Bombay, 3 Edition, 443-453, 1999.
Subrahmanyam C. V. S.. Text Book of Physical Pharmaceutics, New Delhi, Vallabh Prakashan, 2 Edition, 253-261, 2001.
Aulton M. E.. Pharmaceutics: The Science of Dosage Form Design, Churchill Livingstone, London, 2 Edition, 322-334, 2002.
Wu P. C., Tsai P. J., Lin S. C.and Y. B. Huang. Formulation optimization of arecoline patches, The Scientific World Journal, Vol. pp. 1-7, 2014.
Prasanthi D. and Lakshmi P. K. Effect of chemical enhancers in transdermal permeation of alfuzosin hydrochloride, ISRN Pharmaceutics, Vol. 4, pp. 1-8, 2012.
Prashar M., Aggarwal G., Harikumar S. L. Formulation and evaluation of transdermal drug delivery system of simvastatin using natural and synthetic permeation enhancers, Der Pharmacia Lettre, Vol. 6(5), pp. 358-368, 2014.
Reddy P. S., Saritha D., Kumar M. R. and Jayaveera K. N. Design and development of transdermal patches for trandolapril, Indian. Journal of Mednodent and Allied Sciences, Vol. 2(1), pp. 34-40, 2014.
Ganju E. and Ganju K. Formulation & evaluation of transdermal patch of acetohexamide, European Journal of Pharmaceutical and Medical research, Vol. 3(7), pp. 233-235, 2017
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
